DPI, BII and EBRD To Exit Africa’s KELIX bio
Source(s): DPI
DPI, BII and EBRD agreed to fully exit KELIX bio, a pan-African pharmaceutical platform, via a sale to Mubadala.
Source(s): DPI
DPI, BII and EBRD agreed to fully exit KELIX bio, a pan-African pharmaceutical platform, via a sale to Mubadala.